Thomas David Hull III Sells 1,844 Shares of Kewaunee Scientific Co. (NASDAQ:KEQU) Stock

Kewaunee Scientific Co. (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 1,844 shares of the business's stock in a transaction on Monday, April 14th. The stock was sold at an average price of $32.44, for a total transaction of $59,819.36. Following the completion of the transaction, the chief executive officer now directly owns 36,072 shares in the company, valued at $1,170,175.68. This trade represents a 4.86 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Thomas David Hull III also recently made the following trade(s):

• On Monday, March 24th, Thomas David Hull III sold 3,000 shares of Kewaunee Scientific stock. The shares were sold at an average price of $45.63, for a total value of $136,890.00.
• On Friday, March 21st, Thomas David Hull III sold 213 shares of Kewaunee Scientific stock. The stock was sold at an average price of $48.53, for a total value of $10,336.89.

Kewaunee Scientific Trading Down 2.5 %

KEQU stock traded down $0.85 during midday trading on Friday, reaching $33.44. 9,461 shares of the company traded hands, compared to its average volume of 23,881. The firm has a market capitalization of $95.47 million, a price-to-earnings ratio of 5.30 and a beta of 0.59. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64. The business has a 50 day moving average of $46.51 and a 200-day moving average of $47.27. Kewaunee Scientific Co. has a 52-week low of $30.82 and a 52-week high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its quarterly earnings data on Wednesday, March 12th. The technology company reported $1.09 earnings per share for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%. The business had revenue of $67.17 million for the quarter.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Kewaunee Scientific from a "buy" rating to a "hold" rating in a research report on Friday, March 14th.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. Invesco Ltd. bought a new position in Kewaunee Scientific in the 4th quarter valued at $6,545,000. Marshall Wace LLP bought a new stake in Kewaunee Scientific during the 4th quarter valued at about $736,000. Truffle Hound Capital LLC bought a new position in Kewaunee Scientific in the 4th quarter worth about $619,000. State Street Corp purchased a new position in shares of Kewaunee Scientific during the third quarter worth approximately $266,000. Finally, Janney Montgomery Scott LLC purchased a new stake in shares of Kewaunee Scientific in the fourth quarter valued at approximately $338,000. Institutional investors own 32.69% of the company's stock.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.